LOXL2 and neoplasm: Among collagen cross-linking enzymes, Lysyl oxidase-like 2 (Loxl2) mRNA was significantly and specifically decreased in WlsΔOB-OS tumor-bearing bones and primary OS cells (Fig. 5a, b).